
Apply Directly
The precision roller places the topical formulation directly over the intended application area according to the finished product directions.
Couldn't load pickup availability

TARGETED GOUT-FLARE FORMULATION
KUBOZN® combines Colchicine with a modern Nanoemulgel Delivery Platform and a large precision roller — a formulation concept built around targeted topical gout-flare care.
WHEN A FLARE TAKES OVER
A gout flare can turn a small finger joint into an area that feels hot, swollen, stiff and intensely sensitive — sometimes making even light contact hard to ignore.

WHY GOUT IS DIFFERENT
Monosodium urate — MSU — crystals can accumulate in and around joints and activate inflammatory pathways including NLRP3 and IL-1β. Those signals participate in recruitment and activation of inflammatory cells such as neutrophils.
APPLICATION MATTERS
Traditional creams can require direct finger massage over an already sensitive area. The KUBOZN® applicator provides a more controlled topical application experience.

Product on the fingertips, less-controlled coverage and direct rubbing over an already sensitive area.
Direct topical contact, controlled coverage and a cleaner application without coating the fingertips.
THE ACTIVE INGREDIENT MATTERS
Colchicine has an established role in gout-flare management. Its pharmacology includes interference with microtubule-dependent inflammatory-cell functions and modulation of processes involving neutrophil activation, recruitment and inflammasome signaling.

THE DELIVERY PLATFORM
A nanoemulgel combines a finely dispersed nanoemulsion with a topical gel matrix. The formulation concept focuses on fine dispersion, even topical coverage and skin-delivery research.

Nanoemulsion technology creates a finely dispersed formulation phase rather than relying only on a coarse conventional mixture.
The nanoemulsion is incorporated into a gel structure designed for practical topical application.
The formulation is designed to spread consistently across the intended application area.
Nanoemulgels are being investigated as formulation platforms for topical and transdermal delivery of suitable active compounds.
A 2026 experimental study developed a colchicine-loaded nanoemulsion with an average droplet size of approximately 14.2 nm and incorporated it into a topical gel matrix.
The specific experimental formulation demonstrated measurable transdermal flux in laboratory testing and was also evaluated in an acute gout mouse model.
These results relate to the specific experimental formulation reported in the published study. They are not finished-product human clinical results for KUBOZN®.FROM APPLICATION TO FORMULATION

The precision roller places the topical formulation directly over the intended application area according to the finished product directions.

The formulation platform is designed around fine dispersion, even topical coverage and consistent contact with the skin.

Colchicine's established role in gout relates to inflammatory processes involved in a gout flare.
Mechanism graphics are illustrative. Finished-product claims should follow validated testing and final approved product labeling.
PRECISION ROLL-ON
The large blue roller provides smooth, direct topical application over the intended area while keeping the formulation off your fingertips.
Smooth, controlled application across the intended area.
Apply where directed without spreading product everywhere.
No thick topical cream left between the fingers.
A full-size topical roll-on format.

DIFFERENT BY DESIGN
The product concept is built around three distinct components: an established gout-flare active, a modern delivery platform and a controlled roll-on application system.
A pharmacologic active with an established role in gout-flare management.
A formulation platform being researched for topical colchicine delivery.
Controlled topical application without coating the fingertips.
REAL LIFE. SIMPLE APPLICATION.

The large roll-on makes topical application straightforward whenever the finished-product directions call for use.
AN IMPORTANT DISTINCTION
Colchicine is associated with management of the inflammatory response during gout flares. It is not a urate-lowering medication and should not be described as directly dissolving MSU crystals.
Its established gout role relates to inflammatory flare management, including pathways involving neutrophil activity.
Long-term serum-urate control is a separate component of gout management.
QUESTIONS BEFORE YOU ROLL?
Colchicine is a pharmacologically active compound with an established role in gout-flare management. Its mechanism involves inflammatory pathways and microtubule-dependent neutrophil activity rather than simply creating a cooling sensation.
No. Colchicine does not directly dissolve MSU crystals or lower serum uric acid. Its established role in gout relates to the inflammatory response associated with a flare.
A nanoemulgel combines a finely dispersed nanoemulsion with a topical gel matrix. This type of formulation is being researched for fine dispersion, skin contact and topical or transdermal drug delivery.
Nanoemulgel should not be described as automatically “homing in” on a gout joint. The more accurate formulation story is fine dispersion, even topical coverage and drug-delivery research.
The roller provides direct and controlled topical application without requiring the user to coat their fingertips in thick cream.
Use according to the dose, frequency, contraindications, warnings and directions on the final approved finished-product labeling.
BUILT AROUND GOUT-FLARE SCIENCE
KUBOZN® Targeted Gout-Flare Roll-On
Colchicine Nanoemulgel • 50 mL / 1.7 FL OZ
